Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenting Yan

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Cancer Cell International|December 10, 2025
Polysaccharides from Huaier induce autophagy-dependent ferroptosis to inhibit breast cancer stem cells in triple-negative breast cancerLinxi Zhou, Ziwei Wu, Kefei Luo, et al.
The Science of the Total Environment|March 20, 2024
Exposure to di-2-ethylhexyl phthalate and breast neoplasm incidence: A cohort studyLijuan Tang, Yimeng Wang, Wenting Yan, et al.
Therapeutic Advances in Medical Oncology|June 30, 2022
Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trialWenting Yan, Xiujuan Wu, Shushu Wang, et al.
Frontiers in Pharmacology|December 23, 2021
Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative ReviewHao Tian, Dandan Ma, Xuanni Tan, et al.
The Plant Journal : for Cell and Molecular Biology|April 29, 2025
Transcriptomic and metabolomic analyses unveil TaASMT3-mediated wheat resistance against stripe rust by promoting melatonin biosynthesisLihua Jiang, Zekai Yuan, Wenting Yan, et al.
International Journal of Surgery (London, England)|April 25, 2025
Patient-reported outcomes by individuals with differentiated thyroid cancer who underwent minimal-access versus conventional open thyroidectomy: a real-world propensity score-matching studyYuqin Zhou, Hao Tian, Guozhi Zhang, et al.
The Oncologist|March 3, 2024
Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast CancerCheng Wang, Qiyun Shi, Guozhi Zhang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 18, 2026
Evaluating diagnostic efficacy of multigene testing in non-diagnostic thyroid nodules by fine-needle aspiration cytology: A prospective cohort studyGuozhi Zhang, Lin Ren, Jia Xiao, et al.
The Oncologist|October 1, 2020
Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I-III HER2-Positive Breast Cancer: A Phase II Clinical TrialJuncheng Xuhong, Xiaowei Qi, Peng Tang, et al.
Nucleic Acids Research|February 20, 2013
A comprehensive analysis of GATA-1-regulated miRNAs reveals miR-23a to be a positive modulator of erythropoiesisYong Zhu, Dongsheng Wang, Fang Wang, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Cancer Cell International|December 10, 2025
Polysaccharides from Huaier induce autophagy-dependent ferroptosis to inhibit breast cancer stem cells in triple-negative breast cancerLinxi Zhou, Ziwei Wu, Kefei Luo, et al.
The Science of the Total Environment|March 20, 2024
Exposure to di-2-ethylhexyl phthalate and breast neoplasm incidence: A cohort studyLijuan Tang, Yimeng Wang, Wenting Yan, et al.
Therapeutic Advances in Medical Oncology|June 30, 2022
Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trialWenting Yan, Xiujuan Wu, Shushu Wang, et al.
Frontiers in Pharmacology|December 23, 2021
Platinum and Taxane Based Adjuvant and Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: A Narrative ReviewHao Tian, Dandan Ma, Xuanni Tan, et al.
The Plant Journal : for Cell and Molecular Biology|April 29, 2025
Transcriptomic and metabolomic analyses unveil TaASMT3-mediated wheat resistance against stripe rust by promoting melatonin biosynthesisLihua Jiang, Zekai Yuan, Wenting Yan, et al.
International Journal of Surgery (London, England)|April 25, 2025
Patient-reported outcomes by individuals with differentiated thyroid cancer who underwent minimal-access versus conventional open thyroidectomy: a real-world propensity score-matching studyYuqin Zhou, Hao Tian, Guozhi Zhang, et al.
The Oncologist|March 3, 2024
Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast CancerCheng Wang, Qiyun Shi, Guozhi Zhang, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 18, 2026
Evaluating diagnostic efficacy of multigene testing in non-diagnostic thyroid nodules by fine-needle aspiration cytology: A prospective cohort studyGuozhi Zhang, Lin Ren, Jia Xiao, et al.
The Oncologist|October 1, 2020
Neoadjuvant Pyrotinib plus Trastuzumab and Chemotherapy for Stage I-III HER2-Positive Breast Cancer: A Phase II Clinical TrialJuncheng Xuhong, Xiaowei Qi, Peng Tang, et al.
Nucleic Acids Research|February 20, 2013
A comprehensive analysis of GATA-1-regulated miRNAs reveals miR-23a to be a positive modulator of erythropoiesisYong Zhu, Dongsheng Wang, Fang Wang, et al.
Pageof 4